SCHEMBL30193752

SCHEMBL30193752

Cc1nnc2oc3c(NCc4ccc(C(C)(O)C(F)(F)F)cc4)ncnc3c2c1C

nearest known ligand 0.65

Predicted protein targets (top 16)

geneUniProtsupporting neighboursconfidence
CHRM4 P08173 10/20 0.65
KDM4E B2RXH2 3/20 0.43
ALDH1A1 P00352 3/20 0.43
HPGD P15428 3/20 0.43
HSD17B10 Q99714 3/20 0.43
MEN1 O00255 1/20 0.43
USP2 O75604 1/20 0.43
MAPK1 P28482 1/20 0.43
KMT2A Q03164 1/20 0.43
L3MBTL1 Q9Y468 1/20 0.38
AURKA O14965 3/20 0.38
RPS6KB1 P23443 3/20 0.38
AURKB Q96GD4 2/20 0.38
LMNA P02545 1/20 0.37
THRB P10828 1/20 0.37
TSHR P16473 1/20 0.37

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL19740855 1.00 CHRM4 (0.65) CHRM4KDM4EALDH1A1HPGDHSD17B10
SCHEMBL19741047 0.91 CHRM4 (0.74) CHRM4KDM4EALDH1A1HPGDHSD17B10
SCHEMBL19741016 0.83 CHRM4 (0.58) CHRM4KDM4EALDH1A1HPGDHSD17B10
SCHEMBL30187336 0.83 CHRM4 (0.60) CHRM4KDM4EALDH1A1HPGDHSD17B10
SCHEMBL19740854 0.83 CHRM4 (0.60) CHRM4KDM4EALDH1A1HPGDHSD17B10
SCHEMBL30187346 0.83 CHRM4 (0.58) CHRM4KDM4EALDH1A1HPGDHSD17B10
SCHEMBL30187858 0.81 CHRM4 (0.55) CHRM4KDM4EALDH1A1HPGDHSD17B10
SCHEMBL19741011 0.81 THRB (0.55) CHRM4KDM4EALDH1A1HPGDHSD17B10
SCHEMBL30193492 0.81 THRB (0.55) CHRM4KDM4EALDH1A1HPGDHSD17B10
SCHEMBL19740871 0.79 CHRM4 (1.00) CHRM4KDM4EALDH1A1HPGDHSD17B10

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20250026764-A1 POSITIVE ALLOSTERIC MODULATORS OF THE MUSCARINIC ACETYLCHOLINE RECEPTOR M4 UNIV VANDERBILT (US) 2025-01-23 US disclosed
US-20230348490-A1 POSITIVE ALLOSTERIC MODULATORS OF THE MUSCARINIC ACETYLCHOLINE RECEPTOR M4 VANDERBILT UNIVERSITY 2023-11-02 US disclosed
US-20230014109-A1 POSITIVE ALLOSTERIC MODULATORS OF THE MUSCARINIC ACETYLCHOLINE RECEPTOR M4 VANDERBILT UNIVERSITY 2023-01-19 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20230014109-A1 POSITIVE ALLOSTERIC MODULATORS OF THE MUSCARINIC ACETYLCHOLINE RECEPTOR M4 CHRM4, CHRM5, CHRM2 CHRM4 1/4885KDM4E 894/4885ALDH1A1 3751/4885
US-20230348490-A1 POSITIVE ALLOSTERIC MODULATORS OF THE MUSCARINIC ACETYLCHOLINE RECEPTOR M4 CHRM4, CHRM5, CHRM2 CHRM4 1/4885KDM4E 894/4885ALDH1A1 3751/4885
US-20250026764-A1 POSITIVE ALLOSTERIC MODULATORS OF THE MUSCARINIC ACETYLCHOLINE RECEPTOR M4 CHRM4, CHRM5, CHRM2 CHRM4 1/4885KDM4E 894/4885ALDH1A1 3751/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.